Mass General Brigham Ventures
Mass General Brigham Ventures is the strategic venture capital arm of Mass General Brigham, investing as a participating investor in early-stage healthcare companies across digital health, AI, and biotech that align with the parent system's clinical and research priorities.
- Company typePrivate
- Founded2008
- HeadquartersCambridge, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Mass General Brigham Ventures does
Mass General Brigham Ventures is the strategic venture capital arm of Mass General Brigham Incorporated, a non-profit integrated healthcare system headquartered in Boston, Massachusetts. Founded in 2008 and operating with 11–50 employees from offices in Boston, Cambridge, Salem, and Somerville, the venture unit invests in early-stage healthcare companies whose technologies align with the parent system's clinical and research priorities. Its disclosed portfolio spans pediatric mental health (InStride Health), virtual dementia care (Rippl, subsequently acquired by Harbor Health), AI-powered clinical data abstraction (Carta Healthcare), respiratory therapeutics (Nocion Therapeutics), and preclinical neurodegenerative-disease biotechnology (Violet Therapeutics), with check sizes consistently sized as minority participation rather than lead positions.
The venture unit's investment activity between October 2024 and June 2026 — five rounds across seed, Series A, Series B extension, and Series C totaling over $168 million in combined round size — demonstrates programmatic co-investment alongside ARCH Venture Partners, General Catalyst, GV, F-Prime, UPMC Enterprises, Kin Ventures, and other healthcare-focused funds. The underlying competitive advantage is structural rather than financial: portfolio companies gain potential access to Mass General Brigham's five nationally recognized hospitals, 2.5 million annual patients, nearly $2 billion in annual research funding, and over 3,700 ongoing clinical trials, alongside the parent system's dedicated Artificial Intelligence and Gene and Cell Therapy research institutes.
As a non-profit strategic CVC, Mass General Brigham Ventures is funded by the parent system rather than external LPs, does not disclose revenue or AUM, and participates in rounds as a strategic/clinical-alignment investor. Its business model centers on deal sourcing from the parent system's clinical and research pipeline, portfolio diversification across therapeutic areas and stages, and downstream commercial validation through MGB's integrated care delivery network rather than on management fees or fund performance metrics typical of for-profit VCs.
Mass General Brigham Ventures firmographics
Firmographics- Name
- Mass General Brigham Ventures
- Legal name
- Mass General Brigham Incorporated
- Website
- https://massgeneralbrigham.org
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mass General Brigham Ventures is the strategic venture capital arm of Mass General Brigham, investing as a participating investor in early-stage healthcare companies across digital health, AI, and biotech that align with the parent system's clinical and research priorities.
- Ownership category
- akta.pro rank
Mass General Brigham Ventures industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Other Financial Vehicles (52599), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)
- akta.pro secondary industries
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD), Early-Stage Venture Capital (Series A/B) (FSANAAAB), Late-Stage Venture Capital (Series C+) (FSANAAAC)
Keywords
Where Mass General Brigham Ventures is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Mass General Brigham Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
Distribution channels3 records
Marketing channels3 records
Mass General Brigham Ventures product offering
Product offeringCore offering
Mass General Brigham Ventures is the venture capital arm of Mass General Brigham, providing strategic equity investments in early-stage healthcare companies. It deploys capital across seed, Series A, Series B, and Series C rounds into startups operating in pediatric mental health, neurodegenerative disease biotechnology, dementia care, clinical data abstraction, and chronic cough therapeutics aligned with the parent system's clinical and research priorities.
Product overview
Mass General Brigham Ventures operates as the venture capital investment arm of Mass General Brigham, an integrated healthcare system. The entity invests in healthcare innovation companies across various stages and therapeutic areas, including pediatric mental health (InStride Health), neurodegenerative disease biotechnology (Violet Therapeutics), dementia care (Rippl), and clinical data management (Carta Healthcare). The investment portfolio spans from seed to Series C funding rounds.
Differentiator
Problem solved
Functional benefit
Brands
- Mass General Brigham Health Plan: Health insurance plan offered by the Mass General Brigham system
- Patient Gateway
- World Medical Innovation Forum
- MGH Institute of Health Professions
- Salem Hospital
Products and services
- Venture Capital Investment Services
Companies that use Mass General Brigham Ventures
Customer profileSegments3 records
Ideal customer profiles1 record
Mass General Brigham Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Mass General Brigham Ventures partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Dana-Farber Cancer InstitutecoreDana-Farber Cancer Institute and Mass General Brigham agreed to collaborate on physician assistants following what was described as a 'breakup' between the two Boston hospital systems. The physician assistants are employed by Dana-Farber but contracted to work in Brigham's inpatient oncology units, representing a collaborative employment arrangement.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Mass General Brigham Ventures competitors and assessment
Company assessmentDirect peers
- Amed Ventures: A CVC platform representing a consortium of non-profit health systems investing jointly in healthcare startups. Highly comparable as a multi-system healthcare CVC with overlapping strategic thesis and similar fund mechanics.
- UPMC Enterprises: The venture and innovation arm of UPMC, a large integrated payer-provider system. Directly comparable as a hospital-system CVC; notably co-invested with Mass General Brigham Ventures in Carta Healthcare's Series B1, evidencing direct overlap in deal-making.
- Kaiser Permanente Ventures: The venture capital arm of Kaiser Permanente, one of the largest U.S. integrated non-profit healthcare systems. Directly comparable as a health-system-affiliated CVC investing across stages in digital health, care delivery, and biotech, with strategic alignment to its parent.
- Northwell Holdings: The venture and investment arm of Northwell Health, New York's largest healthcare system. Comparable as a large integrated health system's venture function deploying capital into healthcare innovation.
- Mayo Clinic Ventures: The venture arm of Mayo Clinic, one of the most prestigious U.S. academic medical centers. Comparable as an AMC-affiliated investor and licensor focused on translating clinical and research IP into venture-backed companies.
- Cleveland Clinic Innovations: The commercialization and venture arm of Cleveland Clinic, an academic medical center. Comparable as an academic medical system's venture function that commercializes internal innovation and invests in external healthcare startups.
- Bon Secours Mercy Health Ventures: The venture and innovation function of Bon Secours Mercy Health, a large Catholic non-profit health system. Comparable as a non-profit system-affiliated CVC investing in healthcare innovation companies.
- Echo Health Ventures: A healthcare-focused CVC formed as a joint venture between Cambia Health Solutions and Mosaic Health Solutions. Directly comparable as a payer/provider CVC; co-invested with MGB Ventures in InStride Health's Series C.
Broad incumbents
- Optum Ventures: The venture arm of UnitedHealth Group's Optum, the largest healthcare services and innovation platform in the U.S. Comparable as a healthcare-focused CVC, but with substantially larger scale and broader strategic remit than MGB Ventures.
Emerging players
- Cedars-Sinai Accelerator: The accelerator and venture function of Cedars-Sinai Medical Center, a leading U.S. academic medical center. Comparable as an AMC-affiliated healthcare innovation investor, though with a stronger accelerator-program orientation than MGB Ventures.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Mass General Brigham Ventures social profiles
Digital presenceMass General Brigham Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mass General Brigham Ventures leadership team
Management profileNumber of profiles
Mass General Brigham Ventures subsidiaries and ownership
Company hierarchySubsidiaries10 records
Mass General Brigham Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mass General Brigham Ventures M&A and investment
M&A and investmentM&A
Investments40 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mass General Brigham Ventures
What does Mass General Brigham Ventures do?
Mass General Brigham Ventures is the venture capital arm of Mass General Brigham, providing strategic equity investments in early-stage healthcare companies. It deploys capital across seed, Series A, Series B, and Series C rounds into startups operating in pediatric mental health, neurodegenerative disease biotechnology, dementia care, clinical data abstraction, and chronic cough therapeutics aligned with the parent system's clinical and research priorities.
Is Mass General Brigham Ventures a public or private company?
Mass General Brigham Ventures is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Mass General Brigham Ventures founded?
Mass General Brigham Ventures was founded in 2008. It employs 11 to 50 people.
Where is Mass General Brigham Ventures based?
Mass General Brigham Ventures is headquartered in Cambridge, United States, in the North America region.
Who are Mass General Brigham Ventures's main competitors?
Direct peers on record are Amed Ventures, UPMC Enterprises, Kaiser Permanente Ventures, Northwell Holdings, Mayo Clinic Ventures, Cleveland Clinic Innovations, Bon Secours Mercy Health Ventures and Echo Health Ventures. Optum Ventures is listed as a broad incumbent. Cedars-Sinai Accelerator is listed as an emerging player.
Does Mass General Brigham Ventures have an API?
No public API is recorded for Mass General Brigham Ventures.
What industry is Mass General Brigham Ventures in?
Mass General Brigham Ventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms, with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52599 and its SIC code is 6282.